Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panagiotis Petrou

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Journal of Medical Economics|October 5, 2023
Cost-effectiveness of Left Atrial Appendage Closure with WATCHMAN device for non-valvular atrial fibrillation patients in Japan. Are the policy implications big in Japan?Panagiotis Petrou
Pharmacological Research|June 6, 2017
Value-Based pricing and the end of pharmaceutical pricing as we know it? A case study on sorafenib and axitinibPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|January 22, 2019
A systematic review of the economic evaluations of non-calcium-containing phosphate binders, sevelamer and Lanthanum, in end-stage renal disease patients with hyperphosphatemiaPanagiotis Petrou
Journal of Medical Economics|July 12, 2018
The quest for the in medio stat virtus price in the oncology sectorPanagiotis Petrou
Value in Health Regional Issues|October 28, 2017
Battling Tuberculosis beyond antibioticsPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|June 8, 2023
Is it a chimera? A systematic review of the economic evaluations of CAR-T cell therapy - an updatePanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|January 28, 2023
Budget impact analysis of daratumumab for light-chain amyloidosis in CyprusPanagiotis Petrou
Applied Health Economics and Health Policy|April 21, 2015
An Interrupted Time-Series Analysis to Assess Impact of Introduction of Co-Payment on Emergency Room Visits in CyprusPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|May 5, 2021
Assessing the pricing and benefits of oncology products: an updatePanagiotis Petrou
International Journal of Public Health|October 5, 2018
Seeking to introduce a pharmacoeconomics framework in CyprusPanagiotis Petrou
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Journal of Medical Economics|October 5, 2023
Cost-effectiveness of Left Atrial Appendage Closure with WATCHMAN device for non-valvular atrial fibrillation patients in Japan. Are the policy implications big in Japan?Panagiotis Petrou
Pharmacological Research|June 6, 2017
Value-Based pricing and the end of pharmaceutical pricing as we know it? A case study on sorafenib and axitinibPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|January 22, 2019
A systematic review of the economic evaluations of non-calcium-containing phosphate binders, sevelamer and Lanthanum, in end-stage renal disease patients with hyperphosphatemiaPanagiotis Petrou
Journal of Medical Economics|July 12, 2018
The quest for the in medio stat virtus price in the oncology sectorPanagiotis Petrou
Value in Health Regional Issues|October 28, 2017
Battling Tuberculosis beyond antibioticsPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|June 8, 2023
Is it a chimera? A systematic review of the economic evaluations of CAR-T cell therapy - an updatePanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|January 28, 2023
Budget impact analysis of daratumumab for light-chain amyloidosis in CyprusPanagiotis Petrou
Applied Health Economics and Health Policy|April 21, 2015
An Interrupted Time-Series Analysis to Assess Impact of Introduction of Co-Payment on Emergency Room Visits in CyprusPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|May 5, 2021
Assessing the pricing and benefits of oncology products: an updatePanagiotis Petrou
International Journal of Public Health|October 5, 2018
Seeking to introduce a pharmacoeconomics framework in CyprusPanagiotis Petrou
Pageof 6